The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure

European Neuropsychopharmacology

Volumn 22, Issue 3, 2012, Pages 205-221

  Koresh, Ori ^a   Kozlovsky, Nitsan ^a   Kaplan, Zeev ^a   Zohar, Joseph ^b   Matar, Michael A ^a   Cohen, Hagit ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Agomelatine; Animal model; Circadian rhythms; Circadian related genes; Period 1; Period 2; Post traumatic stress disorder

Indexed keywords

AGOMELATINE; BRAIN PROTEIN; MESSENGER RNA; PER1 PROTEIN; PER2 PROTEIN;

ACOUSTIC STARTLE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CIRCADIAN RHYTHM; CONTROLLED STUDY; EXTREME BEHAVIORAL RESPONSE; FRONTAL CORTEX; GENE EXPRESSION; GENETIC VARIABILITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MENTAL DISEASE; MINIMAL BEHAVIORAL RESPONSE; NEUROBIOLOGY; NEUROPATHOLOGY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STARTLE REFLEX; STRESS; SUPRACHIASMATIC NUCLEUS;

ACETAMIDES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CIRCADIAN RHYTHM; GENE EXPRESSION; PERIOD CIRCADIAN PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; STRESS, PSYCHOLOGICAL;

EID: 84856540461     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.07.012     Document Type: Article

References (66)

1. Akiyama M., Kirihara T., Takahashi S., Minami Y., Yoshinobu Y., Moriya T., Shibata S. Modulation of mPer1 gene expression by anxiolytic drugs in mouse cerebellum. Br. J. Pharmacol. 1999, 128:1616-1622.
2. Arushanian E.B., Beier E.V. The contrary effect of destruction of the dorsal hippocampus and of the suprachiasmatic nucleus of the hypothalamus on the rhythmic organization of behavior and on anxiety in rats. Zh. Vyssh. Nerv. Deiat. Im. I P Pavlova 1999, 49:264-270.
3. Aston-Jones G., Chen S., Zhu Y., Oshinsky M.L. A neural circuit for circadian regulation of arousal. Nat. Neurosci. 2001, 4:732-738.
4. Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reichardt H.M., Schutz G., Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000, 289:2344-2347.
5. Belle M.D., Diekman C.O., Forger D.B., Piggins H.D. Daily electrical silencing in the mammalian circadian clock. Science 2009, 326:281-284.
6. Benca R., Duncan M.J., Frank E., McClung C., Nelson R.J., Vicentic A. Biological rhythms, higher brain function, and behavior: gaps, opportunities, and challenges. Brain Res. Rev. 2009, 62(1):57-70.
7. Bourin M., Mocaer E., Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J. Psychiatry Neurosci. 2004, 29:126-133.
8. Brewer J.M., Yannielli P.C., Harrington M.E. Neuropeptide Y differentially suppresses per1 and per2 mRNA induced by light in the suprachiasmatic nuclei of the golden hamster. J. Biol. Rhythms 2002, 17:28-39.
9. Bunney W.E., Bunney B.G. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 2000, 22:335-345.
10. Bunney J.N., Potkin S.G. Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br. Med. Bull. 2008, 86:23-32.
11. Challet E. Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 2007, 148:5648-5655.
12. Chaudhury D., Colwell C.S. Circadian modulation of learning and memory in fear-conditioned mice. Behav. Brain Res. Rev. 2002, 133:95-108.
13. Chaudhury D., Wang L.M., Colwell C.S. Circadian regulation of hippocampal long-term potentiation. J. Biol. Rhythms 2005, 20:225-236.
14. Cohen H., Joseph Z., Matar M. The relevance of differential response to trauma in an animal model of post-traumatic stress disorder. Biol. Psychiatry 2003, 53:463-473.
15. Cohen H., Zohar J., Matar M.A., Zeev K., Loewenthal U., Richter-Levin G. Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 2004, 29:1962-1970.
16. Cohen H., Zohar J., Matar M.A., Kaplan Z., Geva A.B. Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol. Psychiatry 2005, 58:640-650.
17. Cohen H, Liu T, Kozlovsky N, Zohar J, Mathé A (Under Review) The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorder.
18. Dagyte G., Crescente I., Postema F., Seguin L., Gabriel C., Mocaer E., Boer J.A., Koolhaas J.M. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behav. Brain Res. 2011, 218:121-128.
19. Darlington T., Wager-Smith K., Ceriani M., Staknis D., Gekakis N., Steeves T., Weitz C., Takahashi J., Kay S. Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and tim. Science 1998, 280:1599-1603.
20. Dickmeis T. Glucocorticoids and the circadian clock. J. Endocrinol. 2009, 200:3-22.
21. Easton A., Arbuzova J., Turek F.W. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav. 2003, 2:11-19.
22. Feillet C.A., Mendoza J., Albrecht U., Pevet P., Challet E. Forebrain oscillators ticking with different clock hands. Mol. Cell. Neurosci. 2008, 37:209-221.
23. Fountoulakis K.N. Disruption of biological rhythms as a core problem and therapeutic target in mood disorders: the emerging concept of 'rhythm regulators'. Ann. Gen. Psychiatry 2010, 9:3.
24. Gekakis N., Staknis D., Nguyen H., Davis F., Wilsbacher L., King D., Takahashi J., Weitz C. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280:1564-1569.
25. Gonzalez M.M., Aston-Jones G. Circadian regulation of arousal: role of the noradrenergic locus coeruleus system and light exposure. Sleep 2006, 29:1327-1336.
26. Gorwood P. Restoring circadian rhythms: a new way to successfully manage depression. J. Psychopharmacol. 2010, 24:15-19.
27. Hampp G., Ripperger J.A., Houben T., Schmutz I., Blex C., Perreau-Lenz S., Brunk I., Spanagel R., Ahnert-Hilger G., Meijer J.H., Albrecht U. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr. Biol. 2008, 18:678-683.
28. Harms E., Young M.W., Saez L. CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found. Symp. 2003, 253:267-277. discussion 102-9, 277-84.
29. Iitaka C., Miyazaki K., Akaike T., Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J. Biol. Chem. 2005, 280:29397-29402.
30. Jin X., Shearman L., Weaver D., Zylka M., deVries G., Reppert S. A molecular mechanism in regulating rhythmic output from the suprachiasmatic circadian clock. Cell 1999, 96:57-68.
31. Kasper S., Hajak G., Wulff K., Hoogendijk W.J., Montejo A.L., Smeraldi E., Rybakowski J.K., Quera-Salva M.A., Wirz-Justice A.M., Picarel-Blanchot F., Bayle F.J. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J. Clin. Psychiatry 2010, 71:109-120.
32. Ko C.H., Takahashi J.S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 2006, 15:271-277.
33. Kondratov R.V., Antoch M.P. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol. 2007, 17:311-317.
34. Kozlovsky N., Matar M.A., Kaplan Z., Kotler M., Zohar J., Cohen H. Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int. J. Neuropsychopharmacol. 2007, 10:741-758.
35. Kozlovsky N., Matar M.A., Kaplan Z., Zohar J., Cohen H. A distinct pattern of intracellular glucocorticoid-related responses is associated with extreme behavioral response to stress in an animal model of post-traumatic stress disorder. Eur. Neuropsychopharmacol. 2009, 19:759-771.
36. Kurabayashi N., Hirota T., Harada Y., Sakai M., Fukada Y. Phosphorylation of mCRY2 at Ser557 in the hypothalamic suprachiasmatic nucleus of the mouse. Chronobiol. Int. 2006, 23:129-134.
37. Lamont E.W., Legault-Coutu D., Cermakian N., Boivin D.B. The role of circadian clock genes in mental disorders. Dialogues Clin. Neurosci. 2007, 9:333-342.
38. Laudenslager M.L., Noonan C., Jacobsen C., Goldberg J., Buchwald D., Bremner J.D., Vaccarino V., Manson S.M. Salivary cortisol among American Indians with and without posttraumatic stress disorder (PTSD): gender and alcohol influences. Brain Behav. Immun. 2009, 23:658-662.
39. Lemoine P., Guilleminault C., Alvarez E. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J. Clin. Psychiatry 2007, 68:1723-1732.
40. Loiseau F., Le Bihan C., Hamon M., Thiebot M.H. Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam. Eur. Neuropsychopharmacol. 2006, 16:417-428.
41. Maldonado R., Smadja C., Mazzucchelli C., Sassone-Corsi P. Altered emotional and locomotor responses in mice deficient in the transcription factor CREM. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14094-14099.
42. McClung C.A. Circadian genes, rhythms and the biology of mood disorders. Pharmacol. Ther. 2007, 114:222-232.
43. Mellman T.A., Brown D.D., Jenifer E.S., Hipolito M.M., Randall O.S. Posttraumatic stress disorder and nocturnal blood pressure dipping in young adult African Americans. Psychosom. Med. 2009, 71:627-630.
44. Mendlewicz J. Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 2009, 23(Suppl. 2):15-26.
45. Millan M., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J. Pharmacol. Exp. Ther. 2003, 954-964.
46. Millan M., Brocco M., Gobert A., Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology 2005, 177:448-458.
47. Miller M.W., Gronfier C. Diurnal variation of the startle reflex in relation to HPA-axis activity in humans. Psychophysiology 2006, 43:297-301.
48. Papp M., Gruca P., Boyer P., Mocaer E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 2003, 28:694-703.
49. Papp M., Litwa E., Gruca P., Mocaer E. Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav. Pharmacol. 2006, 17:9-18.
50. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, Elsevier Academic Press.
51. Perreau-Lenz S., Sanchis-Segura C., Leonardi-Essmann F., Schneider M., Spanagel R. Development of morphine-induced tolerance and withdrawal: involvement of the clock gene mPer2. Eur. Neuropsychopharmacol. 2010, 20:509-517.
52. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., Lazaropoulou C., Papassotiriou I., Tsiantis J., Chrousos G.P. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999.
53. Reppert S., Weaver D. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
54. Segall L.A., Milet A., Tronche F., Amir S. Brain glucocorticoid receptors are necessary for the rhythmic expression of the clock protein, PERIOD2, in the central extended amygdala in mice. Neurosci. Lett. 2009, 457:58-60.
55. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., Lascorz J., Depner M., Holzberg D., Soyka M., Schreiber S., Matsuda F., Lathrop M., Schumann G., Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat. Med. 2005, 11:35-42.
56. Stratmann M., Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J. Biol. Rhythms 2006, 21:494-506.
57. Takahashi J., Hong H., Ko C., McDearmon E. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 2008, 9:764-775.
58. Tuma J., Strubbe J., Mocaer E., Koolhaas J. S20098 affects the freerunning rhythms of body temperature and activity and decreases lightinduced phase delays of circadian rhythms of the rat. Chronobiol. Int. 2001, 18:781-799.
59. Tuma J., Strubbe J.H., Mocaer E., Koolhaas J.M. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN. Eur. Neuropsychopharmacol. 2005, 15:545-555.
60. Turek F.W. From circadian rhythms to clock genes in depression. Int. Clin. Psychopharmacol. 2007, 22(Suppl. 2):S1-S8.
61. Ulmer C.S., Calhoun P.S., Edinger J.D., Wagner H.R., Beckham J.C. Sleep disturbance and baroreceptor sensitivity in women with posttraumatic stress disorder. J. Trauma. Stress. 2009, 22:643-647.
62. Wang L.M., Dragich J.M., Kudo T., Odom I.H., Welsh D.K., O'Dell T.J., Colwell C.S. Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviour. ASN Neuro 2009, 1.
63. Yamamoto T., Nakahata Y., Tanaka M., Yoshida M., Soma H., Shinohara K., Yasuda A., Mamine T., Takumi T. Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element. J. Biol. Chem. 2005, 280:42036-42043.
64. Yamazaki S., Numano R., Abe M., Hida A., Takahashi R., Ueda M., Block G.D., Sakaki Y., Menaker M., Tei H. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000, 288:682-685.
65. Yang S., Van Dongen H.P., Wang K., Berrettini W., Bucan M. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol. Psychiatry 2009, 14:143-155.
66. Yoo S.H., Yamazaki S., Lowrey P.L., Shimomura K., Ko C.H., Buhr E.D., Siepka S.M., Hong H.K., Oh W.J., Yoo O.J., Menaker M., Takahashi J.S. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5339-5346.